Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer

Overview

Journal Int J Gynecol Cancer

Specialties Gynecology & Obstetrics
Oncology

Date 2015 Sep 3

PMID 26332389

Citations 17

Authors

Xiang Zhou

Chang-Juan Xu

Jun-Xian Wang

Ting Dai

Ya-Ping Ye

Yan-Mei Cui

Wen-Ting Liao

Xin-Lin Wu

Jian-Ping Ou

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study is to investigate the clinicopathologic significance and potential role of metastasis-associated in colon cancer-1 (MACC1) in the progression of cervical cancer.

Methods: MACC1 expression was examined in cervical cancer cell lines, 6 matched cervical cancer tissues, and adjacent noncancerous tissues using Western blotting and real-time reverse transcriptase polymerase chain reaction. MACC1 protein expression and localization were determined in 181 paraffin-embedded archived cervical cancer samples using immunohistochemistry. Statistical analyses were applied to evaluate the clinicopathologic significance. The effects of MACC1 on cell migration, invasion, and angiogenesis were examined using migration assay, wound healing assay, 3-dimensional morphogenesis assay, and chicken chorioallantoic membrane assay. Western blotting was performed to examine the impact of MACC1 on the Akt and nuclear factor κB signaling pathways.

Results: Both protein and messenger RNA levels of MACC1 was up-regulated in cervical cancer cell lines and cervical cancer tissues, as compared with normal tissues. High MACC1 expression was detected in 96 (53%) of 181 of the cervical cancer tissues. In addition, high MACC1 expression correlated significantly with aggressiveness of cervical cancer, including International Federation of Gynecology and Obstetric stage (P = 0.001), pelvic lymph node metastasis (P = 0.004), recurrence (P = 0.037), and poor survival (P = 0.001). Moreover, enforced expression of MACC1 in cervical cancer cell lines significantly enhanced cell migration, invasion, and angiogenesis. Conversely, knockdown of MACC1 caused an inhibition of cell migration, invasion, and angiogenesis. Up-regulation of MACC1 increased, but knockdown of MACC1 decreased the expression of matrix metalloproteinase-2 and matrix metalloproteinase-9. Furthermore, enforced expression of MACC1 could enhance, but knockdown of MACC1 could reduce AKT and nuclear factor κB pathway activity.

Conclusions: Our findings suggest that MACC1 protein, as a valuable marker of cervical cancer prognosis, plays an important role in the progression of human cervical cancer cells.

Citing Articles

MACC1 revisited - an in-depth review of a master of metastasis.

Schope P, Torke S, Kobelt D, Kortum B, Treese C, Dumbani M Biomark Res. 2024; 12(1):146.

PMID: 39580452 PMC: 11585957. DOI: 10.1186/s40364-024-00689-4.

MACC1-induced migration in tumors: Current state and perspective.

Hohmann T, Hohmann U, Dehghani F Front Oncol. 2023; 13:1165676.

PMID: 37051546 PMC: 10084939. DOI: 10.3389/fonc.2023.1165676.

MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer.

Lv M, Jiao Y, Yang B, Ye M, Di W, Su W Biology (Basel). 2023; 12(3).

PMID: 36979146 PMC: 10045309. DOI: 10.3390/biology12030455.

MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer.

Gullu N, Smith J, Herrmann P, Stein U Nutrients. 2022; 14(22).

PMID: 36432477 PMC: 9692505. DOI: 10.3390/nu14224792.

MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.

Mei J, Zhu C, Pan L, Li M Bioengineered. 2021; 13(1):61-70.

PMID: 34939526 PMC: 8805864. DOI: 10.1080/21655979.2021.2006567.

References

Lee S, Bae S, Kim K, Lee W, Rhim B, Hong K . High glucose enhances MMP-2 production in adventitial fibroblasts via Akt1-dependent NF-kappaB pathway. FEBS Lett. 2007; 581(22):4189-94. DOI: 10.1016/j.febslet.2007.07.058. View

John A, Tuszynski G . The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 2001; 7(1):14-23. DOI: 10.1007/BF03032599. View

Nair A, Venkatraman M, Maliekal T, Nair B, Karunagaran D . NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene. 2003; 22(1):50-8. DOI: 10.1038/sj.onc.1206043. View

Mazzone M, Comoglio P . The Met pathway: master switch and drug target in cancer progression. FASEB J. 2006; 20(10):1611-21. DOI: 10.1096/fj.06-5947rev. View

Wang Z, Li Z, Wu C, Wang Y, Xia Y, Chen L . MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med Oncol. 2013; 31(1):790. DOI: 10.1007/s12032-013-0790-6. View

Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C . Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med. 2011; 9:166. PMC: 3192685. DOI: 10.1186/1479-5876-9-166. View

Baldwin A . Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest. 2001; 107(3):241-6. PMC: 199203. DOI: 10.1172/JCI11991. View

Lin L, Huang H, Ma H, Liu J, Wang L, Huang N . MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene. 2014; 34(21):2700-10. DOI: 10.1038/onc.2014.204. View

Li J, Jia H, Xie L, Wang X, Wang X, He H . Association of constitutive nuclear factor-kappaB activation with aggressive aspects and poor prognosis in cervical cancer. Int J Gynecol Cancer. 2009; 19(8):1421-6. DOI: 10.1111/IGC.0b013e3181b70445. View

10.

Chundong G, Uramoto H, Onitsuka T, Shimokawa H, Iwanami T, Nakagawa M . Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res. 2011; 31(4):1141-5. View

11.

Kokoszynska K, Krynski J, Rychlewski L, Wyrwicz L . Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol. 2009; 56(2):317-23. View

12.

Shehata M . Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells. Cancer Cell Int. 2005; 5(1):10. PMC: 1090600. DOI: 10.1186/1475-2867-5-10. View

13.

Guo L, Lu W, Zhang X, Luo D, Zhang H . Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer. Int J Clin Exp Pathol. 2014; 7(7):4150-5. PMC: 4129030. View

14.

Guo T, Yang J, Yao J, Zhang Y, Da M, Duan Y . Expression of MACC1 and c-Met in human gastric cancer and its clinical significance. Cancer Cell Int. 2013; 13(1):121. PMC: 4029370. DOI: 10.1186/1475-2867-13-121. View

15.

Birchmeier C, Birchmeier W, Gherardi E, Vande Woude G . Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003; 4(12):915-25. DOI: 10.1038/nrm1261. View

16.

Zhang R, Shi H, Chen Z, Wu Q, Ren F, Huang H . Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res. 2011; 30:83. PMC: 3182136. DOI: 10.1186/1756-9966-30-83. View

17.

Gien L, Covens A . Lymph node assessment in cervical cancer: prognostic and therapeutic implications. J Surg Oncol. 2008; 99(4):242-7. DOI: 10.1002/jso.21199. View

18.

Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I . MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2008; 15(1):59-67. DOI: 10.1038/nm.1889. View

19.

Kawamura M, Saigusa S, Toiyama Y, Tanaka K, Okugawa Y, Hiro J . Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res. 2012; 32(4):1527-31. View

20.

Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke K . Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One. 2012; 7(11):e49249. PMC: 3498161. DOI: 10.1371/journal.pone.0049249. View